NCT05204121View on ClinicalTrials.gov

Phase Ib Study of Safety, Tolerability and Pharmacokinetics of Elpida Once Weekly in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

December 18, 2018

Primary Completion Date

April 2, 2019

Study Completion Date

April 2, 2019

Conditions

HIV Infections

Interventions

DRUG

Elpida

elsulfavirine, capsules

Trial Locations (1)

119991

Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Viriom

INDUSTRY